{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:39:44Z","timestamp":1790311184666,"version":"4.1.0"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T00:00:00Z","timestamp":1607472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Recently, an increasing number of studies have revealed that N6-methyladenosine (m6A) functions as a significant post-transcriptional modification which plays a critical role in the occurrence and progression of enriched tumors by regulating coding and non-coding RNA biogenesis. However, the biological function of m6A in breast cancer remains largely unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>In this study, we used a series of bioinformatic databases and tools to jointly analyze the expression of m6A methylation transferases (METTL3, METTL14, WTAP, RBM15, RBM15B and ZC3H13) and investigate the prognostic value of METTL14 and ZC3H13 in breast cancer. Besides, we analyzed the downstream carcinogenic molecular mechanisms related to METTL14 and ZC3H13 and their relationship with immune infiltration in breast tumor tissues.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The results showed that METTL14 and ZC3H13 were the down-regulated m6A methylation transferases in breast cancer. Survival outcome analysis suggested that abnormally low expression of METTL14 and ZC3H13 could predict unfavorable prognosis in four breast cancer subtypes. Moreover, their down-regulation was associated with ER-, PR- and triple-negative breast cancer patients, as well as tumor progression (increased Scarff, Bloom and Richardson grade status and Nottingham Prognostic Index classification). Co-expression analysis revealed that METTL14 and ZC3H13 had a strong positive correlation with APC, an antagonist of the Wnt signaling pathway, indicating they might cooperate in regulating proliferation, invasion, and metastasis of tumor cells. METTL14, ZC3H13, and APC expression levels had significant positive correlation with infiltrating levels of CD4+ T cells, CD8+ T cells, neutrophils, macrophages, and dendritic cells, and negative correlation with Treg cells in breast cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study demonstrated that down-regulation of METTL14 and ZC3H13 which act as two tumor suppressor genes was found in breast cancer and predicted poor prognosis. Their abnormal expression promoted breast cancer invasion by affecting pathways related to tumor progression and mediating immunosuppression.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2020.578963","type":"journal-article","created":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T18:42:28Z","timestamp":1607539348000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":110,"title":["Analysis of N6-Methyladenosine Methyltransferase Reveals METTL14 and ZC3H13 as Tumor Suppressor Genes in Breast Cancer"],"prefix":"10.3389","volume":"10","author":[{"given":"Peng-Ju","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Cheng","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Jing","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Fan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Rui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,12,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30026-9","article-title":"Immunotherapy and\u00a0targeted therapy combinations in metastatic breast cancer","volume":"20","author":"Esteva","year":"2019","journal-title":"Lancet\u00a0Oncol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/nrclinonc.2015.123","article-title":"Precision medicine for metastatic breast cancer\u2013limitations and solutions","volume":"12","author":"Arnedos","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.02.002","article-title":"Epigenetic modulations and lineage plasticity in advanced prostate cancer","volume":"31","author":"Ge","year":"2020","journal-title":"Ann Oncol"},{"key":"B4","article-title":"Genetic and epigenetic aspects of breast cancer progression and therapy","volume":"34","author":"Byler","year":"2014","journal-title":"Anticancer Res"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.71.10.3971","article-title":"Identification of methylated nucleosides in messenger RNA from Novikoff hepatoma cells","volume":"71","author":"Desrosiers","year":"1974","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B6","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.tig.2019.10.011","article-title":"The Biogenesis and Precise Control of RNA m(6)A Methylation","volume":"36","author":"Huang","year":"2020","journal-title":"Trends Genet"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-018-0040-8","article-title":"Dynamic transcriptomic m(6)A decoration: writers, erasers, readers and functions in RNA metabolism","volume":"28","author":"Yang","year":"2018","journal-title":"Cell Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12943-020-01216-3","article-title":"Mechanism of RNA modification N6-methyladenosine in human cancer","volume":"19","author":"Zhou","year":"2020","journal-title":"Mol Cancer"},{"key":"B9","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12943-020-01207-4","article-title":"Interaction between N(6)-methyladenosine (m(6)A) modification and noncoding RNAs in cancer","volume":"19","author":"Chen","year":"2020","journal-title":"Mol Cancer"},{"key":"B10","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12943-019-1065-4","article-title":"METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer","volume":"18","author":"Yue","year":"2019","journal-title":"Mol Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12943-019-1053-8","article-title":"WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1","volume":"18","author":"Chen","year":"2019","journal-title":"Mol Cancer"},{"key":"B12","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12943-020-1146-4","article-title":"METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST","volume":"19","author":"Yang","year":"2020","journal-title":"Mol Cancer"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1593\/neo.07112","article-title":"Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles","volume":"9","author":"Rhodes","year":"2007","journal-title":"Neoplasia"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-0307","article-title":"TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells","volume":"77","author":"Li","year":"2017","journal-title":"Cancer Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gks1008","article-title":"The UCSC Cancer Genomics Browser: update 2013","volume":"41","author":"Goldman","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ygeno.2008.02.003","article-title":"UCSC genome browser tutorial","volume":"92","author":"Zweig","year":"2008","journal-title":"Genomics"},{"key":"B17","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-009-0674-9","article-title":"An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients","volume":"123","author":"Gyorffy","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"B20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1755-8794-2-18","article-title":"PrognoScan: a new database for meta-analysis of the prognostic value of genes","volume":"2","author":"Mizuno","year":"2009","journal-title":"BMC Med Genomics"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-011-1457-7","article-title":"bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer","volume":"131","author":"Jezequel","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"B22","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz401","article-title":"WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs","volume":"47","author":"Liao","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gks1094","article-title":"STRING v9.1: protein-protein interaction networks, with increased coverage and integration","volume":"41","author":"Franceschini","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btq675","article-title":"Cytoscape 2.8: new features for data integration and network visualization","volume":"27","author":"Smoot","year":"2011","journal-title":"Bioinformatics"},{"key":"B26","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13059-016-1028-7","article-title":"Comprehensive analyses of tumor immunity: implications for cancer immunotherapy","volume":"17","author":"Li","year":"2016","journal-title":"Genome Biol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaa407","article-title":"TIMER2.0 for analysis of tumor-infiltrating immune cells","volume":"48","author":"Li","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21388","article-title":"The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"B29","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/nyas.14027","article-title":"The Wnt signaling pathway: a potential therapeutic target against cancer","volume":"1443","author":"Ghosh","year":"2019","journal-title":"Ann N Y Acad Sci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.20517\/2394-4722.2020.63","article-title":"Wnts and the hallmarks of cancer","volume":"39","author":"Zhong","year":"2020","journal-title":"CancerMetastasis Rev"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-020-09878-7","article-title":"The emerging role of Wnt5a in the promotion of a pro-inflammatoryand immunosuppressive tumor microenvironment","volume":"39","author":"Lopez-Bergami","year":"2020","journal-title":"Cancer Metastasis Rev"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-1321","article-title":"Dendritic Cells, the T-cell-inflamed Tumor Microenvironment andImmunotherapy Treatment Response","volume":"26","author":"Garris","year":"2020","journal-title":"Clin Cancer Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-020-0253-2","article-title":"Role of RNA modifications in cancer","volume":"20","author":"Barbieri","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2020.02.004","article-title":"m(6)A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer","volume":"37","author":"Huang","year":"2020","journal-title":"Cancer Cell"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01407","article-title":"N(6)-Methyladenosine: A Novel RNA Imprint in Human Cancer","volume":"9","author":"Yu","year":"2019","journal-title":"Front Oncol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4416","article-title":"The N(6)-methyladenosine (m(6)A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells","volume":"23","author":"Vu","year":"2017","journal-title":"Nat Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/nature24678","article-title":"Promoter-bound METTL3 maintains myeloid leukaemia by m(6)A-dependent translation control","volume":"552","author":"Barbieri","year":"2017","journal-title":"Nature"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2017.4219","article-title":"The epitranscriptome m6A writer METTL3 promotes chemo- and radioresistance in pancreatic cancer cells","volume":"52","author":"Taketo","year":"2018","journal-title":"Int J Oncol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ebiom.2019.07.068","article-title":"N(6)-methyladenosine modification of ITGA6 mRNA promotes the development and progression of bladder cancer","volume":"47","author":"Jin","year":"2019","journal-title":"EBioMedicine"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2017.351","article-title":"Essential role of METTL3-mediated m(6)A modification in glioma stem-like cells maintenance and radioresistance","volume":"37","author":"Visvanathan","year":"2018","journal-title":"Oncogene"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00115","article-title":"METTL3 Promotes the Progression of Gastric Cancer via Targeting the MYC Pathway","volume":"10","author":"Yang","year":"2020","journal-title":"Front Oncol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28885","article-title":"METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N(6) -methyladenosine-dependent primary MicroRNA processing","volume":"65","author":"Ma","year":"2017","journal-title":"Hepatology"},{"key":"B43","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12943-019-1004-4","article-title":"RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3","volume":"18","author":"Niu","year":"2019","journal-title":"Mol Cancer"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1602883113","article-title":"Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m6;A-demethylation of NANOG mRNA","volume":"113","author":"Zhang","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B45","doi-asserted-by":"publisher","first-page":"4473","DOI":"10.3390\/ijms21124473","article-title":"Inactivation of APC Induces CD34 Upregulation to PromoteEpithelial-Mesenchymal Transition and Cancer Stem Cell Traits in Pancreatic Cancer","volume":"21","author":"Hsieh","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-018-0045-z","article-title":"Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation","volume":"20","author":"Huang","year":"2018","journal-title":"Nat Cell Biol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12943-019-1038-7","article-title":"METTL3 facilitates tumor progression via an m(6)A-IGF2BP2-dependent mechanism in colorectal carcinoma","volume":"18","author":"Li","year":"2019","journal-title":"Mol Cancer"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104794","article-title":"Targeting the \u03b2-catenin signaling for cancertherapy","volume":"160","author":"Zhang","year":"2020","journal-title":"Pharmacol Res"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02872","article-title":"Wnt Signaling and Its Significance Within the Tumor Microenvironment: Novel Therapeutic Insights","volume":"10","author":"Patel","year":"2019","journal-title":"Front Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.semcancer.2019.11.011","article-title":"Oncogenic signaling pathways associated with immune evasion andresistance to immune checkpoint inhibitors in cancer","volume":"65","author":"Kobayashi","year":"2019","journal-title":"Semin CancerBiol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aau5240","article-title":"Pharmacological inhibition of \u03b2-catenin\/BCL9 interaction overcomes resistance to immune checkpoint blockades by modulating T(reg) cells","volume":"5","author":"Feng","year":"2019","journal-title":"Sci Adv"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2020.578963\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T11:27:56Z","timestamp":1610278076000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2020.578963\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,9]]},"references-count":51,"alternative-id":["10.3389\/fonc.2020.578963"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2020.578963","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-39451\/v1","asserted-by":"object"}]},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,9]]},"article-number":"578963"}}